Repozytorium

A novel immunosuppressory peptide originating from the ubiquitin sequence.

Autorzy

Paweł Pasikowski

Tomasz Goździewicz

Piotr Stefanowicz

Jolanta Artym

Michał Zimecki

Zbigniew Szewczuk

Rok wydania

2011

Czasopismo

Peptides

Numer woluminu

32

Strony

2418-2427

DOI

10.1016/j.peptides.2011.10.002

Kolekcja

Naukowa

Język

Angielski

Typ publikacji

Artykuł

Streszczenie

Ubiquitin is a conservative polypeptide present in every eukaryotic cell. Apart from its involvement in proteasomal degradation and other intracellular signal pathways, it was suggested to play an important role as the extracellular immunomodulator and antimicrobial agent. Moreover, ubiquitin-derived peptides were shown to express significant biological activities. Our previous studies showed a high immunosuppressive potency of the ubiquitin peptic hydrolysate in which we identified over 70 different peptides. The present work focuses on synthesizing the most abundant of these peptides and investigating their immunomodulatory potency. The peptide VKTLTGKTI possessed the highest immunosuppressory activity in AFC experiments, comparable to the previously described LEDGRTLSDY sequence (a previously discovered ubiquitin-derived peptide). Moreover, some of the investigated peptides expressed immunostimulatory effects. These findings support the idea that ubiquitin, together with products of its degradation, could represent a self-regulating immunoregulatory system. Peptide VKTLTGKTI was also tested for its activity to prolong the skin graft survival in mice. The results showed that the investigated peptide significantly extended the skin transplant rejection time, therefore it could be considered as a potential supplementary medicine in the post-transplantation therapy. Moreover, we synthesized two analogs of investigated peptides, first designed to mimic the non-linear epitope consisting of ubiquitin 16-21 and ubiquitin 52-57 fragments, and second designed to mimic the ubiquitin 5-13 hairpin. We also tested their immunosuppressory activity in in vitro experiments.

Adres publiczny

http://dx.doi.org/10.1016/j.peptides.2011.10.002

Strona internetowa wydawcy

http://www.elsevier.com

Podobne publikacje
2010

Novel peptide conjugates : heterocyclic modifications of the immunomodulatory ubiquitin fragment.

Kluczyk Alicja, Ratajska Małgorzata, Staszewska Anna, Cebrat Marek, Bartosz-Bechowski Hubert, Stefanowicz Piotr, Zimecki Michał, Szewczuk Zbigniew

2009

Specific interactions of Bi(III) with the Cys-Xaa-Cys unit of a peptide sequence.

Rowińska-Żyrek Magdalena, Valensin Daniela, Szyrwiel Łukasz, Grzonka Z., Kozłowski Henryk

1999

The effect of halogenation on blood-brain barrier permeability of a novel peptide drug.

Gentry C. L., Egleton R. D., Gillespie T. J., Abbruscato H. B, Bartosz-Bechowski Hubert, Hruby V. J., Davis T. P.